ProfileGDS4718 / 1553923_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 27% 25% 34% 26% 26% 25% 25% 28% 25% 33% 23% 25% 30% 30% 27% 26% 32% 22% 25% 20% 25% 29% 25% 32% 30% 30% 33% 20% 27% 29% 27% 33% 27% 32% 26% 21% 27% 21% 28% 23% 30% 24% 34% 25% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.4191127
GSM549102patient 115, normal, homogenized [OPG study]4.3325625
GSM549104patient 119, normal, homogenized [OPG study]4.7208234
GSM549108patient 138, normal, homogenized [OPG study]4.4147726
GSM549119patient 077, normal, homogenized [OPG study]4.3816126
GSM549133patient 032, cancer, homogenized [OPG study]4.2675525
GSM549139patient 042, cancer, homogenized [OPG study]4.3000925
GSM549099patient 107, normal, homogenized [OPG study]4.4826628
GSM549109patient 139, normal, homogenized [OPG study]4.3693925
GSM549110patient 046, normal, homogenized [OPG study]4.6519833
GSM549114patient 063, normal, homogenized [OPG study]4.2169823
GSM549122patient 082, normal, homogenized [OPG study]4.3527625
GSM549134patient 033, cancer, homogenized [OPG study]4.5451730
GSM549136patient 036, cancer, homogenized [OPG study]4.4594330
GSM549140patient 044, cancer, homogenized [OPG study]4.3566127
GSM549111patient 047, normal, homogenized [OPG study]4.3495926
GSM549113patient 057, normal, homogenized [OPG study]4.5831232
GSM549132patient 031, cancer, homogenized [OPG study]4.198622
GSM549137patient 038, cancer, homogenized [OPG study]4.3368225
GSM549142patient 047, cancer, homogenized [OPG study]4.2261820
GSM549100patient 110, normal, homogenized [OPG study]4.3612125
GSM549107patient 135, normal, homogenized [OPG study]4.4616629
GSM549115patient 068, normal, homogenized [OPG study]4.2693225
GSM549116patient 072, normal, homogenized [OPG study]4.6202732
GSM549120patient 078, normal, homogenized [OPG study]4.5471630
GSM549131patient 030, cancer, homogenized [OPG study]4.4784530
GSM549118patient 074, normal, homogenized [OPG study]4.668533
GSM549129patient 027, cancer, homogenized [OPG study]4.1597520
GSM549123patient 088, normal, homogenized [OPG study]4.3892627
GSM549124patient 006, cancer, homogenized [OPG study]4.5215129
GSM549126patient 015, cancer, homogenized [OPG study]4.3855827
GSM549128patient 025, cancer, homogenized [OPG study]4.6340633
GSM549103patient 117, normal, homogenized [OPG study]4.4582127
GSM549117patient 073, normal, homogenized [OPG study]4.6156232
GSM549138patient 041, cancer, homogenized [OPG study]4.3728826
GSM549141patient 045, cancer, homogenized [OPG study]4.1409721
GSM549130patient 028, cancer, homogenized [OPG study]4.4422827
GSM549101patient 111, normal, homogenized [OPG study]4.2082921
GSM549105patient 128, normal, homogenized [OPG study]4.4812928
GSM549106patient 134, normal, homogenized [OPG study]4.2041723
GSM549112patient 048, normal, homogenized [OPG study]4.5276430
GSM549125patient 011, cancer, homogenized [OPG study]4.3063924
GSM549127patient 024, cancer, homogenized [OPG study]4.7236634
GSM549135patient 035, cancer, homogenized [OPG study]4.2873625